BBI-4000, 15%

Phase 2Completed

0 views this week 0 watching💤 Quiet

Interest: 25/100

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

Phase 2

Phase 3

Approved

Indication / Disease

Hyperhidrosis

Conditions

Hyperhidrosis

Trial Timeline

Mar 8, 2016 → Oct 4, 2016

NCT ID

NCT02682238

About BBI-4000, 15%

BBI-4000, 15% is a phase 2 stage product being developed by Botanix Pharmaceuticals for Hyperhidrosis. The current trial status is completed. This product is registered under clinical trial identifier NCT02682238. Target conditions include Hyperhidrosis.

What happened to similar drugs?

0 of 6 similar drugs in Hyperhidrosis were approved

Approved (0) Terminated (0) Active (6)

🔄glycopyrronium Topical WipesJourney MedicalPhase 3

🔄Glycopyrronium Topical WipesJourney MedicalPhase 3

🔄glycopyrronium Topical WipesJourney MedicalPhase 3

🔄Sofpironium Bromide, 15% + VehicleBotanix PharmaceuticalsPhase 3

🔄Sofpironium Bromide Gel, 15% + VehicleBotanix PharmaceuticalsPhase 3

🔄Sofpironium Bromide Gel, 5% + Sofpironium Bromide Gel, 15%Botanix PharmaceuticalsPhase 3

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT02682238	Phase 2	Completed	Mar 8, 2016	Oct 4, 2016	Hyperhidrosis

Competing Products

14 competing products in Hyperhidrosis

See all competitors

Product	Company	Stage	Hype Score
Umeclidinium + Vehicle	GSK plc	Phase 2	35
Dose 1 of glycopyrrolate, 2.0% QD + Dose 2 of glycopyrrolate, 3.0% QD + Dose 1 of glycopyrronium, 2.5% QD + Dose 2 of glycopyrronium, 3.75% QD	Journey Medical	Phase 2	25
glycopyrronium Topical Wipes	Journey Medical	Phase 3	30
Glycopyrronium Topical Wipes	Journey Medical	Phase 3	30
glycopyrrolate, 1.0% + glycopyrrolate, 2.0% + glycopyrrolate, 3.0% + glycopyrrolate, 4.0%	Journey Medical	Phase 2	25
glycopyrronium Topical Wipes	Journey Medical	Phase 3	30
Glycopyrronium cloth, 2.4% + Vehicle	Journey Medical	Phase 2	25
BBI-4000 gel, 5% + BBI-4000 gel, 10% + BBI-4000 gel, 15% + Vehicle (Placebo)	Botanix Pharmaceuticals	Phase 2	25
BBI-4000 Gel, 5% + BBI-4000 Gel, 10% + BBI-4000 Gel, 15% + Vehicle	Botanix Pharmaceuticals	Phase 2	25
Sofpironium Bromide, 15% + Vehicle	Botanix Pharmaceuticals	Phase 3	30
BBI-4000	Botanix Pharmaceuticals	Phase 1	19
Sofpironium Bromide Gel, 15% + Vehicle	Botanix Pharmaceuticals	Phase 3	30
Sofpironium Bromide Gel, 5% + Sofpironium Bromide Gel, 15%	Botanix Pharmaceuticals	Phase 3	30
Sofpironium Bromide Gel, 15%	Botanix Pharmaceuticals	Phase 2	25